Clinical Trials Browser

Phase 1 × Recurrence × Ramucirumab × Clear all

NCT02564198 2021-08-17

A Study of Ramucirumab (LY3009806) in Children With Refractory Solid Tumors

Phase 1 Completed

29 enrolled 12 charts

Neoplasms, Recurrence, Central Nervous System Neoplasms